 | • レポートコード：GIR-105X03146 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Medical Devices & Consumables |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、がんバイオマーカーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。がんバイオマーカーの種類別市場規模（タンパク質バイオマーカー、遺伝子バイオマーカー）、用途別市場規模（診断、研究、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・がんバイオマーカーの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Thermo Fisher Scientific、Bio-Rad Laboratories、Roche Diagnostics、Qiagen、Illumina、GE Healthcare、Agilent Technologies、Biomérieux SA、Merck & Co.、Abbott Laboratories、Becton, Dickinson and Company、Danaher Corporation、Myriad Genetics、Sysmex Corporation、Hologic、Quest Diagnostics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：タンパク質バイオマーカー、遺伝子バイオマーカー ・用途別分析2016年-2026年：診断、研究、その他 ・がんバイオマーカーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・がんバイオマーカーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・がんバイオマーカーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・がんバイオマーカーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・がんバイオマーカーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cancer Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cancer Biomarker size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Cancer Biomarker market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cancer Biomarker market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Protein Biomarker
Genetic Biomarker
Market segment by Application can be divided into
Diagnostics
Research
Others
The key market players for global Cancer Biomarker market are listed below:
Thermo Fisher Scientific
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomérieux SA
Merck & Co.
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Quest Diagnostics
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Cancer Biomarker product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Biomarker, with price, sales, revenue and global market share of Cancer Biomarker from 2019 to 2021.
Chapter 3, the Cancer Biomarker competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Biomarker breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Cancer Biomarker market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Cancer Biomarker sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Cancer Biomarker Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Biomarker Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Protein Biomarker
1.2.3 Genetic Biomarker
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Biomarker Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Diagnostics
1.3.3 Research
1.3.4 Others
1.4 Global Cancer Biomarker Market Size & Forecast
1.4.1 Global Cancer Biomarker Sales in Value (2016-2026))
1.4.2 Global Cancer Biomarker Sales in Volume (2016-2026)
1.4.3 Global Cancer Biomarker Price by Type (2016-2026) & (USD/Unit)
1.5 Global Cancer Biomarker Production Capacity Analysis
1.5.1 Global Cancer Biomarker Total Production Capacity (2016-2026)
1.5.2 Global Cancer Biomarker Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Biomarker Market Drivers
1.6.2 Cancer Biomarker Market Restraints
1.6.3 Cancer Biomarker Trends Analysis
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Cancer Biomarker Product and Services
2.1.4 Thermo Fisher Scientific Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bio-Rad Laboratories
2.2.1 Bio-Rad Laboratories Details
2.2.2 Bio-Rad Laboratories Major Business
2.2.3 Bio-Rad Laboratories Cancer Biomarker Product and Services
2.2.4 Bio-Rad Laboratories Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Roche Diagnostics
2.3.1 Roche Diagnostics Details
2.3.2 Roche Diagnostics Major Business
2.3.3 Roche Diagnostics Cancer Biomarker Product and Services
2.3.4 Roche Diagnostics Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Qiagen
2.4.1 Qiagen Details
2.4.2 Qiagen Major Business
2.4.3 Qiagen Cancer Biomarker Product and Services
2.4.4 Qiagen Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Illumina
2.5.1 Illumina Details
2.5.2 Illumina Major Business
2.5.3 Illumina Cancer Biomarker Product and Services
2.5.4 Illumina Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 GE Healthcare
2.6.1 GE Healthcare Details
2.6.2 GE Healthcare Major Business
2.6.3 GE Healthcare Cancer Biomarker Product and Services
2.6.4 GE Healthcare Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Agilent Technologies
2.7.1 Agilent Technologies Details
2.7.2 Agilent Technologies Major Business
2.7.3 Agilent Technologies Cancer Biomarker Product and Services
2.7.4 Agilent Technologies Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Biomérieux SA
2.8.1 Biomérieux SA Details
2.8.2 Biomérieux SA Major Business
2.8.3 Biomérieux SA Cancer Biomarker Product and Services
2.8.4 Biomérieux SA Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Merck & Co.
2.9.1 Merck & Co. Details
2.9.2 Merck & Co. Major Business
2.9.3 Merck & Co. Cancer Biomarker Product and Services
2.9.4 Merck & Co. Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Abbott Laboratories
2.10.1 Abbott Laboratories Details
2.10.2 Abbott Laboratories Major Business
2.10.3 Abbott Laboratories Cancer Biomarker Product and Services
2.10.4 Abbott Laboratories Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Becton, Dickinson and Company
2.11.1 Becton, Dickinson and Company Details
2.11.2 Becton, Dickinson and Company Major Business
2.11.3 Becton, Dickinson and Company Cancer Biomarker Product and Services
2.11.4 Becton, Dickinson and Company Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Danaher Corporation
2.12.1 Danaher Corporation Details
2.12.2 Danaher Corporation Major Business
2.12.3 Danaher Corporation Cancer Biomarker Product and Services
2.12.4 Danaher Corporation Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Myriad Genetics
2.13.1 Myriad Genetics Details
2.13.2 Myriad Genetics Major Business
2.13.3 Myriad Genetics Cancer Biomarker Product and Services
2.13.4 Myriad Genetics Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Sysmex Corporation
2.14.1 Sysmex Corporation Details
2.14.2 Sysmex Corporation Major Business
2.14.3 Sysmex Corporation Cancer Biomarker Product and Services
2.14.4 Sysmex Corporation Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Hologic
2.15.1 Hologic Details
2.15.2 Hologic Major Business
2.15.3 Hologic Cancer Biomarker Product and Services
2.15.4 Hologic Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Quest Diagnostics
2.16.1 Quest Diagnostics Details
2.16.2 Quest Diagnostics Major Business
2.16.3 Quest Diagnostics Cancer Biomarker Product and Services
2.16.4 Quest Diagnostics Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Cancer Biomarker Sales by Manufacturer
3.1 Global Cancer Biomarker Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Cancer Biomarker Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Cancer Biomarker
3.4 Market Concentration Rate
3.4.1 Top 3 Cancer Biomarker Manufacturer Market Share
3.4.2 Top 6 Cancer Biomarker Manufacturer Market Share
3.5 Global Cancer Biomarker Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Cancer Biomarker Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cancer Biomarker Market Size by Region
4.1.1 Global Cancer Biomarker Sales in Volume by Region (2016-2026)
4.1.2 Global Cancer Biomarker Revenue by Region (2016-2026)
4.2 North America Cancer Biomarker Revenue (2016-2026)
4.3 Europe Cancer Biomarker Revenue (2016-2026)
4.4 Asia-Pacific Cancer Biomarker Revenue (2016-2026)
4.5 South America Cancer Biomarker Revenue (2016-2026)
4.6 Middle East and Africa Cancer Biomarker Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Cancer Biomarker Sales in Volume by Type (2016-2026)
5.2 Global Cancer Biomarker Revenue by Type (2016-2026)
5.3 Global Cancer Biomarker Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Cancer Biomarker Sales in Volume by Application (2016-2026)
6.2 Global Cancer Biomarker Revenue by Application (2016-2026)
6.3 Global Cancer Biomarker Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Cancer Biomarker Sales by Type (2016-2026)
7.2 North America Cancer Biomarker Sales by Application (2016-2026)
7.3 North America Cancer Biomarker Market Size by Country
7.3.1 North America Cancer Biomarker Sales in Volume by Country (2016-2026)
7.3.2 North America Cancer Biomarker Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Cancer Biomarker Sales by Type (2016-2026)
8.2 Europe Cancer Biomarker Sales by Application (2016-2026)
8.3 Europe Cancer Biomarker Market Size by Country
8.3.1 Europe Cancer Biomarker Sales in Volume by Country (2016-2026)
8.3.2 Europe Cancer Biomarker Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Cancer Biomarker Sales by Type (2016-2026)
9.2 Asia-Pacific Cancer Biomarker Sales by Application (2016-2026)
9.3 Asia-Pacific Cancer Biomarker Market Size by Region
9.3.1 Asia-Pacific Cancer Biomarker Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Cancer Biomarker Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Cancer Biomarker Sales by Type (2016-2026)
10.2 South America Cancer Biomarker Sales by Application (2016-2026)
10.3 South America Cancer Biomarker Market Size by Country
10.3.1 South America Cancer Biomarker Sales in Volume by Country (2016-2026)
10.3.2 South America Cancer Biomarker Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cancer Biomarker Sales by Type (2016-2026)
11.2 Middle East & Africa Cancer Biomarker Sales by Application (2016-2026)
11.3 Middle East & Africa Cancer Biomarker Market Size by Country
11.3.1 Middle East & Africa Cancer Biomarker Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Cancer Biomarker Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Cancer Biomarker Typical Distributors
12.3 Cancer Biomarker Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Cancer Biomarker Revenue by Type, (USD Million), 2021-2026
Table 2. Global Cancer Biomarker Revenue by Application, (USD Million), 2021-2026
Table 3. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 4. Thermo Fisher Scientific Major Business
Table 5. Thermo Fisher Scientific Cancer Biomarker Product and Services
Table 6. Thermo Fisher Scientific Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Bio-Rad Laboratories Major Business
Table 9. Bio-Rad Laboratories Cancer Biomarker Product and Services
Table 10. Bio-Rad Laboratories Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table 12. Roche Diagnostics Major Business
Table 13. Roche Diagnostics Cancer Biomarker Product and Services
Table 14. Roche Diagnostics Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Qiagen Basic Information, Manufacturing Base and Competitors
Table 16. Qiagen Major Business
Table 17. Qiagen Cancer Biomarker Product and Services
Table 18. Qiagen Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Illumina Basic Information, Manufacturing Base and Competitors
Table 20. Illumina Major Business
Table 21. Illumina Cancer Biomarker Product and Services
Table 22. Illumina Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 24. GE Healthcare Major Business
Table 25. GE Healthcare Cancer Biomarker Product and Services
Table 26. GE Healthcare Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 28. Agilent Technologies Major Business
Table 29. Agilent Technologies Cancer Biomarker Product and Services
Table 30. Agilent Technologies Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Biomérieux SA Basic Information, Manufacturing Base and Competitors
Table 32. Biomérieux SA Major Business
Table 33. Biomérieux SA Cancer Biomarker Product and Services
Table 34. Biomérieux SA Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 36. Merck & Co. Major Business
Table 37. Merck & Co. Cancer Biomarker Product and Services
Table 38. Merck & Co. Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 40. Abbott Laboratories Major Business
Table 41. Abbott Laboratories Cancer Biomarker Product and Services
Table 42. Abbott Laboratories Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 44. Becton, Dickinson and Company Major Business
Table 45. Becton, Dickinson and Company Cancer Biomarker Product and Services
Table 46. Becton, Dickinson and Company Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Danaher Corporation Basic Information, Manufacturing Base and Competitors
Table 48. Danaher Corporation Major Business
Table 49. Danaher Corporation Cancer Biomarker Product and Services
Table 50. Danaher Corporation Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table 52. Myriad Genetics Major Business
Table 53. Myriad Genetics Cancer Biomarker Product and Services
Table 54. Myriad Genetics Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 56. Sysmex Corporation Major Business
Table 57. Sysmex Corporation Cancer Biomarker Product and Services
Table 58. Sysmex Corporation Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Hologic Basic Information, Manufacturing Base and Competitors
Table 60. Hologic Major Business
Table 61. Hologic Cancer Biomarker Product and Services
Table 62. Hologic Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 64. Quest Diagnostics Major Business
Table 65. Quest Diagnostics Cancer Biomarker Product and Services
Table 66. Quest Diagnostics Cancer Biomarker Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Cancer Biomarker Sales by Manufacturer (2019-2021e) & (K Units)
Table 68. Global Cancer Biomarker Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Cancer Biomarker, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Cancer Biomarker Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and Cancer Biomarker Production Site of Key Manufacturer
Table 72. Cancer Biomarker New Entrant and Capacity Expansion Plans
Table 73. Cancer Biomarker Mergers & Acquisitions in the Past Five Years
Table 74. Global Cancer Biomarker Sales by Region (2016-2021e) & (K Units)
Table 75. Global Cancer Biomarker Sales by Region (2021-2026) & (K Units)
Table 76. Global Cancer Biomarker Revenue by Region (2016-2021e) & (USD Million)
Table 77. Global Cancer Biomarker Revenue by Region (2021-2026) & (USD Million)
Table 78. Global Cancer Biomarker Sales by Type (2016-2021e) & (K Units)
Table 79. Global Cancer Biomarker Sales by Type (2021-2026) & (K Units)
Table 80. Global Cancer Biomarker Revenue by Type (2016-2021e) & (USD Million)
Table 81. Global Cancer Biomarker Revenue by Type (2021-2026) & (USD Million)
Table 82. Global Cancer Biomarker Price by Type (2016-2021e) & (USD/Unit)
Table 83. Global Cancer Biomarker Price by Type (2021-2026) & (USD/Unit)
Table 84. Global Cancer Biomarker Sales by Application (2016-2021e) & (K Units)
Table 85. Global Cancer Biomarker Sales by Application (2021-2026) & (K Units)
Table 86. Global Cancer Biomarker Revenue by Application (2016-2021e) & (USD Million)
Table 87. Global Cancer Biomarker Revenue by Application (2021-2026) & (USD Million)
Table 88. Global Cancer Biomarker Price by Application (2016-2021e) & (USD/Unit)
Table 89. Global Cancer Biomarker Price by Application (2021-2026) & (USD/Unit)
Table 90. North America Cancer Biomarker Sales by Country (2016-2021e) & (K Units)
Table 91. North America Cancer Biomarker Sales by Country (2021-2026) & (K Units)
Table 92. North America Cancer Biomarker Revenue by Country (2016-2021e) & (USD Million)
Table 93. North America Cancer Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 94. North America Cancer Biomarker Sales by Type (2016-2021e) & (K Units)
Table 95. North America Cancer Biomarker Sales by Type (2021-2026) & (K Units)
Table 96. North America Cancer Biomarker Sales by Application (2016-2021e) & (K Units)
Table 97. North America Cancer Biomarker Sales by Application (2021-2026) & (K Units)
Table 98. Europe Cancer Biomarker Sales by Country (2016-2021e) & (K Units)
Table 99. Europe Cancer Biomarker Sales by Country (2021-2026) & (K Units)
Table 100. Europe Cancer Biomarker Revenue by Country (2016-2021e) & (USD Million)
Table 101. Europe Cancer Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 102. Europe Cancer Biomarker Sales by Type (2016-2021e) & (K Units)
Table 103. Europe Cancer Biomarker Sales by Type (2021-2026) & (K Units)
Table 104. Europe Cancer Biomarker Sales by Application (2016-2021e) & (K Units)
Table 105. Europe Cancer Biomarker Sales by Application (2021-2026) & (K Units)
Table 106. Asia-Pacific Cancer Biomarker Sales by Region (2016-2021e) & (K Units)
Table 107. Asia-Pacific Cancer Biomarker Sales by Region (2021-2026) & (K Units)
Table 108. Asia-Pacific Cancer Biomarker Revenue by Region (2016-2021e) & (USD Million)
Table 109. Asia-Pacific Cancer Biomarker Revenue by Region (2021-2026) & (USD Million)
Table 110. Asia-Pacific Cancer Biomarker Sales by Type (2016-2021e) & (K Units)
Table 111. Asia-Pacific Cancer Biomarker Sales by Type (2021-2026) & (K Units)
Table 112. Asia-Pacific Cancer Biomarker Sales by Application (2016-2021e) & (K Units)
Table 113. Asia-Pacific Cancer Biomarker Sales by Application (2021-2026) & (K Units)
Table 114. South America Cancer Biomarker Sales by Country (2016-2021e) & (K Units)
Table 115. South America Cancer Biomarker Sales by Country (2021-2026) & (K Units)
Table 116. South America Cancer Biomarker Revenue by Country (2016-2021e) & (USD Million)
Table 117. South America Cancer Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 118. South America Cancer Biomarker Sales by Type (2016-2021e) & (K Units)
Table 119. South America Cancer Biomarker Sales by Type (2021-2026) & (K Units)
Table 120. South America Cancer Biomarker Sales by Application (2016-2021e) & (K Units)
Table 121. South America Cancer Biomarker Sales by Application (2021-2026) & (K Units)
Table 122. Middle East & Africa Cancer Biomarker Sales by Country (2016-2021e) & (K Units)
Table 123. Middle East & Africa Cancer Biomarker Sales by Country (2021-2026) & (K Units)
Table 124. Middle East & Africa Cancer Biomarker Revenue by Country (2016-2021e) & (USD Million)
Table 125. Middle East & Africa Cancer Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 126. Middle East & Africa Cancer Biomarker Sales by Type (2016-2021e) & (K Units)
Table 127. Middle East & Africa Cancer Biomarker Sales by Type (2021-2026) & (K Units)
Table 128. Middle East & Africa Cancer Biomarker Sales by Application (2016-2021e) & (K Units)
Table 129. Middle East & Africa Cancer Biomarker Sales by Application (2021-2026) & (K Units)
Table 130. Direct Channel Pros & Cons
Table 131. Indirect Channel Pros & Cons
Table 132. Cancer Biomarker Typical Distributors
Table 133. Cancer Biomarker Typical Customers
List of Figures
Figure 1. Cancer Biomarker Picture
Figure 2. Global Cancer Biomarker Sales Market Share by Type in 2020
Figure 3. Protein Biomarker
Figure 4. Genetic Biomarker
Figure 5. Global Cancer Biomarker Sales Market Share by Application in 2020
Figure 6. Diagnostics
Figure 7. Research
Figure 8. Others
Figure 9. Global Cancer Biomarker Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Cancer Biomarker Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Cancer Biomarker Sales (2016-2026) & (K Units)
Figure 12. Global Cancer Biomarker Price by Type (2016-2026) & (USD/Unit)
Figure 13. Global Cancer Biomarker Production Capacity (2016-2026) & (K Units)
Figure 14. Global Cancer Biomarker Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Cancer Biomarker Market Drivers
Figure 16. Cancer Biomarker Market Restraints
Figure 17. Cancer Biomarker Market Trends
Figure 18. Global Cancer Biomarker Sales Market Share by Manufacturer in 2020
Figure 19. Global Cancer Biomarker Revenue Market Share by Manufacturer in 2020
Figure 20. Cancer Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Cancer Biomarker Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Cancer Biomarker Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Cancer Biomarker Sales Market Share by Region (2016-2026)
Figure 24. Global Cancer Biomarker Revenue Market Share by Region (2016-2026)
Figure 25. North America Cancer Biomarker Revenue (2016-2026) & (USD Million)
Figure 26. Europe Cancer Biomarker Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Cancer Biomarker Revenue (2016-2026) & (USD Million)
Figure 28. South America Cancer Biomarker Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Cancer Biomarker Revenue (2016-2026) & (USD Million)
Figure 30. Global Cancer Biomarker Sales Market Share by Type (2016-2026)
Figure 31. Global Cancer Biomarker Revenue Market Share by Type (2016-2026)
Figure 32. Global Cancer Biomarker Price by Type (2016-2026) & (USD/Unit)
Figure 33. Global Cancer Biomarker Sales Market Share by Application (2016-2026)
Figure 34. Global Cancer Biomarker Revenue Market Share by Application (2016-2026)
Figure 35. Global Cancer Biomarker Price by Application (2016-2026) & (USD/Unit)
Figure 36. North America Cancer Biomarker Sales Market Share by Type (2016-2026)
Figure 37. North America Cancer Biomarker Sales Market Share by Application (2016-2026)
Figure 38. North America Cancer Biomarker Sales Market Share by Country (2016-2026)
Figure 39. North America Cancer Biomarker Revenue Market Share by Country (2016-2026)
Figure 40. United States Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Cancer Biomarker Sales Market Share by Type (2016-2026)
Figure 44. Europe Cancer Biomarker Sales Market Share by Application (2016-2026)
Figure 45. Europe Cancer Biomarker Sales Market Share by Country (2016-2026)
Figure 46. Europe Cancer Biomarker Revenue Market Share by Country (2016-2026)
Figure 47. Germany Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Cancer Biomarker Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Cancer Biomarker Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Cancer Biomarker Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Cancer Biomarker Revenue Market Share by Region (2016-2026)
Figure 56. China Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Cancer Biomarker Sales Market Share by Type (2016-2026)
Figure 63. South America Cancer Biomarker Sales Market Share by Application (2016-2026)
Figure 64. South America Cancer Biomarker Sales Market Share by Country (2016-2026)
Figure 65. South America Cancer Biomarker Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Cancer Biomarker Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Cancer Biomarker Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Cancer Biomarker Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Cancer Biomarker Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Cancer Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
心臓バイオマーカー診断検査キットの世界市場2018-2025 On the basis of product, the global Cardiac Biomarker Diagnostic Test Kits market is segmented into Troponin Test Kits, Myoglobin Test Kits, CK-MB Test Kits and BNP Test Kit.Factors such as rising prevalence and incidence of cardiovascular diseases and public-private initiatives to increase awarenes…- インビトロ結腸直腸がんスクリーニング試験の世界市場予測 2023年：メーカー別、地域別、種類・用途別 In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer. Scope of the Report: This report studies the In-Vitro Colorectal Cancer Screening Tests market status and outlook of Global and major regions, from angles of players, countries, produc…
- がん検査の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Cancer is the second-leading cause of death and disability in the world, only behind heart disease. More people die from cancer around the world than AIDS, Tuberculosis and Malaria combined every year. Scope of the Report: This report studies the Cancer Test market status and outlook of Global and m…
- 前立腺がんの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Prostate cancer is cancer that occurs in the prostate. Scope of the Report: This report studies the Prostate Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and s…
- 卵巣がんの遺伝子治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…